Effect of Warm Water Footbaths With Added Ginger or Mustard Powder on Psychosocial Parameters in Patients With an Oncological Disease
1 other identifier
interventional
36
1 country
1
Brief Summary
A randomized, controlled, three-arm trial to investigate the effects of warm water footbaths with and without the addition of ginger or mustard powder on psychosocial parameters in patients with an oncological disease and in healthy controls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 18, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 18, 2017
CompletedFirst Submitted
Initial submission to the registry
February 13, 2020
CompletedFirst Posted
Study publicly available on registry
February 17, 2020
CompletedFebruary 17, 2020
February 1, 2020
1.7 years
February 13, 2020
February 13, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in subjective feeling of warmth at the feet as assessed by the "Herdecke Warmth Perception Questionnaire" from t1 to t3
Self-reported feeling of warmth at the feet, measured with the "Herdecke Warmth Perception Questionnaire", score between 0=cold and 4=hot
Immediately before the footbath (t1) and 10 minutes following the footbath (t3)
Secondary Outcomes (16)
Change in subjective feeling of warmth at the feet as assessed by the "Herdecke Warmth Perception Questionnaire" from t1 to t2
Immediately before the footbath (t1) and immediately after the footbath (t2)
Change in subjective feeling of warmth in the face as assessed by the "Herdecke Warmth Perception Questionnaire" from t1 to t3
Immediately before the footbath (t1) and 10 minutes following the footbath (t3)
Change in subjective feeling of warmth in the face as assessed by the "Herdecke Warmth Perception Questionnaire" from t1 to t2
Immediately before the footbath (t1) and immediately after the footbath (t2)
Change in subjective feeling of warmth at the hands as assessed by the "Herdecke Warmth Perception Questionnaire" from t1 to t3
Immediately before the footbath (t1) and 10 minutes following the footbath (t3)
Change in subjective feeling of warmth at the hands as assessed by the "Herdecke Warmth Perception Questionnaire" from t1 to t2
Immediately before the footbath (t1) and immediately after the footbath (t2)
- +11 more secondary outcomes
Study Arms (3)
Warm water footbath with ginger powder
EXPERIMENTALFootbath with ginger powder with a maximum duration of 20 minutes.
Warm water footbath with mustard powder
EXPERIMENTALFootbath with mustard powder with a maximum duration of 20 minutes.
Warm water only footbath
ACTIVE COMPARATORWarm water only footbath with a maximum duration of 20 minutes.
Interventions
20-minute footbath with 12 liters of 40°C warm water and an additive of 80g dried ginger powder (reaching up to mid-calf level)
20-minute footbath with 12 liters of 40° C warm water and an additive of 80g dried mustard powder (reaching up to mid-calf level)
20-minute footbath with 12 liters of 40° C warm water without any additive (reaching up to mid-calf level)
Eligibility Criteria
You may qualify if:
- Written informed consent
- Age between 18 and 65 years
- Oncological disorder with at least one chemotherapy or radiation in the treatment history
- Current inpatient treatment in the oncology ward of the Filderklinik (Filderstadt, Germany) with a minimum stay of 4 days
You may not qualify if:
- Infectious disease (with more than 38 °C core body temperature)
- Skin lesion on the lower legs or feet
- Hypersensitivity to mustard or ginger products
- Cardiac arrhythmia
- Pregnancy
- Insufficient knowledge of the German language
- Bedriddenness
- Poor general condition (according to the assessment of the attending physicians)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Arcim Institute
Filderstadt, Baden-Wurttemberg, 70794, Germany
Study Officials
- STUDY DIRECTOR
Jan Vagedes, MD
ARCIM Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 13, 2020
First Posted
February 17, 2020
Study Start
January 15, 2016
Primary Completion
September 18, 2017
Study Completion
September 18, 2017
Last Updated
February 17, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- The data will be made available upon publication for a duration of three months.
- Access Criteria
- The data will be made available to researchers who provide a methodologically sound proposal for use in achieving the goals of the approved proposal.
Deidentified individual participant data will be made available, in addition to study protocol and informed consent form.